KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) Shares Outstanding (Diluted Average) (2017 - 2021)

HCA Healthcare (HCA) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $328.8 million as the latest value for Q4 2021.

  • For Q4 2021, Shares Outstanding (Diluted Average) fell 4.32% year-over-year to $328.8 million; the TTM value through Dec 2021 reached $328.8 million, down 4.32%, while the annual FY2021 figure was $328.8 million, 4.32% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $328.8 million in Q4 2021 for HCA Healthcare, down from $333.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $372.2 million in Q4 2017 and bottomed at $328.8 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $347.3 million, with a median of $348.2 million recorded in 2019.
  • Year-over-year, Shares Outstanding (Diluted Average) decreased 4.55% in 2018 and then dropped 0.23% in 2021.
  • HCA Healthcare's Shares Outstanding (Diluted Average) stood at $372.2 million in 2017, then dropped by 4.55% to $355.3 million in 2018, then decreased by 1.99% to $348.2 million in 2019, then fell by 1.33% to $343.6 million in 2020, then decreased by 4.32% to $328.8 million in 2021.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $328.8 million, $333.2 million, and $332.6 million for Q4 2021, Q3 2021, and Q2 2021 respectively.